Perfluorinated alkyl acids (PFAAs) are a class of chemicals with unique water-, dirt-, and oil-repellent properties; high stability; and resistance to degradation. They are used as surfactants in many industrial processes and consumer products, such as oil and water repellents for fabrics and food-packaging materials ([@r18]). Several PFAAs accumulate in food chains and have been detected in human serum worldwide ([@r8]; [@r17]). Although sources of human exposure are not fully understood, dietary intake is thought to be a major pathway of exposure in general populations, originating either from environmental contamination or migration from food packaging ([@r31], [@r32]). Furthermore, human exposure through drinking water in contaminated areas and dust in indoor environments may be significant ([@r6]; [@r12]; [@r30]).

Two of the most abundant PFAAs in human serum samples are perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS). The half-lives of PFOA and PFOS in human serum have been estimated to be 3.8 years and 5.4 years, respectively ([@r22]). Studies of adult male rats showed that PFOA exposure may cause reduced testosterone levels and increased estradiol levels ([@r19]), and a study on sexually mature mice indicated that PFOS exposure might affect testicular signalling, causing reduced serum testosterone and decreases in epididymal sperm counts ([@r36]). Two cross-sectional studies reported negative associations of PFOS, or high PFOA and PFOS combined, with the proportion of morphologically normal spermatozoa in adult men ([@r16]; [@r33]). Furthermore, in a study of men attending an *in vitro* fertilization clinic, [@r28] reported that luteinizing hormone (LH) and free testosterone were significantly positively correlated with plasma PFOA, although PFOA was not associated with semen characteristics.

Because of the widespread environmental occurrence of PFOA and PFOS, along with their ability to cross the placental barrier ([@r7]; [@r11]; [@r14]), exposure of the developing human fetus to these compounds is inevitable. This is of concern because fetal development of the male reproductive organs may be disturbed by exposure to exogenous factors ([@r15]; [@r26]). In addition, rat studies have suggested the existence of a male programming window---corresponding to gestational weeks 8--14 in humans---during which xenobiotic exposure may affect reproductive hormone balance and impact normal male reproductive development ([@r37]). To our knowledge, potential associations between prenatal exposure to PFOA and PFOS and adverse effects on the human male reproductive system have not been investigated, although potential effects on immune system development were studied by [@r10], who reported decreased antibody responses to childhood diphtheria vaccinations in association with prenatal PFOA and PFOS exposures.

The prospective design of the present study enables us to investigate the hypothesis that *in utero* exposure to PFOA and PFOS is associated with reduced semen quality and testicular size, as well as altered reproductive hormones, in adult men.

Methods
=======

*Population*. Physical examinations were performed on sons of a pregnancy cohort recruited to a study in 1988--1989 in Aarhus, Denmark. Mothers answered a questionnaire on dietary and lifestyle habits and provided a blood sample, which was stored in a biobank at --20°C. Of all invited pregnant women, 80% participated (*n* = 965) ([@r24], [@r25]). In 2008, sons of the pregnancy cohort were invited to answer an Internet-based questionnaire on health and lifestyle habits, and in 2008--2009 they were asked to undergo a physical examination in which they donated a semen sample (which they had produced at home), gave a blood sample to be analyzed for reproductive hormones, and self-measured testicular volumes ([@r35]). Of the 468 sons invited to complete the questionnaire, 176 consented to the physical examination, corresponding to a participation rate of 37.6% of the eligible cohort of sons. Each man provided written informed consent prior to participation, and the study was approved by the Central Denmark Region Committees on Health Research Ethics (registration number M-20070157).

Maternal measurements for PFOA and PFOS serum concentrations were missing for six participants, and one was excluded from all statistical analyses due to azoospermia. Hence, the study population included 169 men ([Figure 1](#f1){ref-type="fig"}).

![Flow chart of recruitment to the physical examination of the follow-up study.](ehp.1205118.g001){#f1}

*Semen collection and physical examination*. Physical examinations were conducted from February 2008 to September 2009. Semen samples were stored in a heating chamber (37°C) until analysis. All participants provided information on time and date of the semen sample collection and spillage during semen sample collection. Testicular volume self-measurements were performed using a Prader orchidometer, a method reported to be valid for testicular size measurement ([@r27]). The examiner measured the height and weight of each participant. Blood samples were taken between 0730 hours and 1330 hours.

*Semen analysis*. For 86% of the samples, semen analysis was initiated within 1 hr of ejaculation; all semen samples were analyzed within 2 hr. We estimated semen volume based on weight (1 g = 1 mL). Conventional analysis of motility and sperm concentration was performed by two laboratory technicians (one in the beginning and the other at the end of the study) according to World Health Organization guidelines ([@r38]). Motility, sperm concentration, and total sperm counts were also assessed by computer-assisted semen analysis (CASA) using CRISMAS Clinical software, version 4.6 (Image House Medical, IHMedical A/S, Copenhagen, Denmark), as previously described ([@r35]). The laboratory continuously participated in the European Society for Human Reproduction and Embryology external quality control program. All tests were in agreement with the quality control standards. Sperm morphology was classified as normal or abnormal using "strict" criteria as described by [@r20].

*Blood sample analysis*. Maternal serum samples were collected in pregnancy week 30 in 1988--1989 and stored at --20°C until analysis in 2010--2011. Concentrations of PFOA and PFOS were determined by column-switching, isotope dilution liquid chromatography--tandem mass spectrometry at the Division of Environmental Medicine, Norwegian Institute of Public Health (Oslo, Norway), as previously described ([@r13]). Limits of quantification were 0.05 ng/mL. Quality of the analytical procedure was monitored by analyzing in-house quality control samples (*n* = 18) and human serum samples from an interlaboratory comparison exercise (*n* = 3). Coefficients of variation (CVs) for PFOA and PFOS for the in-house quality control samples were 11% and 4.4%, respectively, and results of the interlaboratory comparison were within 1 SD of the consensus values.

Serum concentrations of sex hormone-binding globulin (SHBG) were measured using a solid-phase two-site chemiluminescent immunometric assay (IMMULITE® 2000; Siemens Healthcare Diagnostics Products Ltd., Gwynedd, UK) with CVs of 4.5--4.7%; concentrations of LH, follicle-stimulating hormone (FSH), estradiol, and testosterone were analyzed by immunoassays (cobas® 6000 e601; Roche Diagnostics, Mannheim, Germany) at the Department of Clinical Biochemistry, Aarhus University Hospital, with CVs of 1.1--2.4%, 1.9--2.1%, 1.5--2.9%, and 2.2--4.5%, respectively. Undiluted inhibin-B was measured at the Laboratory of Reproductive Biology, Juliane Marie Centre for Women, Children and Reproduction (University Hospital of Copenhagen, Copenhagen, Denmark) using a commercially available ELISA (Oxford Bio-innovation Ltd., Oxfordshire, England, UK) with a detection limit of 20 pg/mL and a CV \< 7%. Measurements below the detection limit for LH (*n* = 1), FSH (*n* = 1), and estradiol (*n* = 4) were recoded to half the detection limit (0.15 IU/L, 0.15 IU/L, and 0.025 nmol/L, respectively).

*Statistical analysis*. Outcome variables included semen parameters \[sperm concentration, total sperm count, semen volume, percentage progressive spermatozoa (rapidly progressive + slowly progressive), and percentage morphologically normal spermatozoa\], mean testicular volume (estimates were comparable for left and right volumes separately), and reproductive hormones (testosterone, estradiol, LH, FSH, SHBG, and inhibin B). Free androgen index (FAI) was calculated as (testosterone/SHBG) × 100.

Differences across tertiles of maternal PFOA and PFOS exposure were estimated using one-way analysis of variance (ANOVA) tests and chi-square tests. We tested crude trends by Spearman's rank correlation test and adjusted trends by multivariable regression analyses by entering PFOA and PFOS as continuous variables in the model. Outcome variables were natural logarithm (ln)-transformed before multivariable regression analysis, and participants were divided into three groups according to tertiles of maternal PFOA \[low (1.26--3.15 ng/mL), medium (≥ 3.15--4.40 ng/mL), and high (≥ 4.40--16.57 ng/mL)\] and PFOS \[low (7.47--18.78 ng/mL), medium (≥ 18.78--24.31 ng/mL), and high (≥ 24.31--54.28 ng/mL)\] concentrations, or according to quintiles (for associations with a significant linear trend). Differences between the two upper tertiles versus the lowest tertile were tested by two-sample Wilcoxon rank-sum (Mann--Whitney) test (crude results) and by multivariable regression analysis for each of the outcome variables, with low PFOA and PFOS groups as referents. Results are presented as adjusted percentage differences with 95% confidence intervals (CIs), which were calculated based on the log scale output from the regression analysis. Multivariable regression results were adjusted for the following *a priori* selected potential confounders: history of reproductive tract disease \[cryptorchidism, hypospadias, inguinal hernia, varicocele, testicular hydrocele, incarcerated hernia, phimosis, testicular torsion, chlamydia, gonorrhea, and epididymitis, combined into one dichotomous variable (any versus none)\], body mass index (continuously in kilograms per meter squared), smoking status (current and party smoker/exsmoker and never smoker), smoking by the participant's mother during pregnancy (yes/no), and socioeconomic status at birth \[total annual income for the household in 1987 \< 200,000 DKK (kroner) or ≥ 200,000 DKK\]. In addition, sperm concentration, total sperm count, percentage progressive spermatozoa, semen volume, and testicular volume were adjusted for abstinence time (≤ 48 hr, 49--120 hr, ≥ 121 hr); sperm concentration for spillage (yes/no); percentage progressive spermatozoa for time from ejaculation to semen analysis (continuous, in minutes); and reproductive hormones for time of day of blood sampling (0730--0929 hours, 0930--1129 hours, later than 1130 hours). Participants reporting spillage during semen sample collection (*n* = 45) were excluded from the analyses of total sperm count and semen volume.

All statistical analyses were performed using Stata 11.2 software (StataCorp, College Station, TX, USA), and a two-tailed probability level of *p* \< 0.05 was considered statistically significant.

Results
=======

The 169 study participants had a median age of 20 years (range, 19--21 years). The mothers' median (25th--75th percentile) plasma concentrations of PFOA and PFOS were 3.8 ng/mL (2.8--4.7 ng/mL) and 21.2 ng/mL (17.4--26.5 ng/mL), respectively, and PFOA and PFOS concentrations were highly correlated (Spearman's rho = 0.73; *p* \< 0.0001).

Characteristics of the study participants according to tertiles of *in utero* PFOA and PFOS exposure are shown in [Table 1](#t1){ref-type="table"}. Characteristics did not differ substantially.

###### 

Characteristics of participants (*n* = 169) and biologic samples according to tertiles of PFOA and PFOS concentrations in maternal serum at gestational week 30.

  Characteristic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              PFOA          PFOS                                                                         
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- ------------- ------------- ------ ------------- ------------- ------------- ------
  Person-related characteristics of sons                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Body mass index (kg/m2; mean ± SD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          22.7 ± 2.6    23.1 ± 3.1    22.5 ± 3.0    0.6a   22.8 ± 2.4    22.6 ± 2.9    23.0 ± 3.4    0.7a
  History of reproductive tract diseaseb                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6 (10.5)      11 (19.6)     8 (14.3)      0.7c   5 (8.8)       9 (16.1)      11 (19.6)     0.7c
  Current/occasional smoker                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   26 (45.6)     28 (50.0)     28 (50.0)     0.5c   29 (50.9)     30 (53.6)     23 (41.1)     0.5c
  Person-related characteristics of mothers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Mother smoked during pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              20 (35.1)     22 (39.3)     11 (19.6)     0.1c   22 (38.6)     18 (32.1)     13 (23.2)     0.3c
  Socioeconomic status (total annual household income 1987; DKK)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  \< 200,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  23 (40.4)     21 (37.5)     16 (28.6)     0.6c   20 (35.1)     23 (41.1)     17 (30.4)     0.8c
  ≥ 200,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   31 (54.4)     29 (51.8)     35 (62.5)     0.6c   32 (56.1)     28 (50.0)     35 (62.5)     0.8c
  Semen and blood-related characteristics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Duration of abstinence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  ≤ 48 hr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     34 (59.7)     27 (48.2)     31 (55.4)     0.6c   37 (64.9)     25 (44.6)     30 (53.6)     0.1c
  49 hr--5 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               22 (38.6)     25 (44.6)     23 (41.1)     0.6c   20 (35.1)     27 (48.2)     23 (41.1)     0.1c
  \> 5 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1 (1.8)       4 (7.1)       2 (3.6)       0.6c   0 (0)         4 (7.1)       3 (5.4)       0.1c
  Minutes from ejaculation to semen analysis (mean ± SD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      45.9 ± 16.1   41.9 ± 21.2   41.2 ± 20.5   0.4a   42.0 ± 17.0   45.1 ± 19.9   42.2 ± 21.1   0.7a
  Spillage occurred at semen sampling                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         16 (28.1)     18 (32.1)     11 (19.6)     0.4c   16 (28.1)     14 (25.0)     15 (26.8)     0.9c
  Time blood was sampled                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  0730--0929 hours                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            16 (28.1)     22 (39.3)     16 (28.6)     0.1c   18 (31.6)     16 (28.6)     20 (35.7)     0.2c
  0930--1129 hours                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            28 (49.1)     23 (41.1)     32 (57.1)     0.1c   22 (38.6)     32 (57.1)     29 (51.8)     0.2c
  Later than 1130 hours                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       13 (22.8)     8 (14.3)      8 (14.3)      0.1c   15 (26.3)     7 (12.5)      7 (12.5)      0.2c
  Values are n (%) unless otherwise stated. Tertiles are as follows: for PFOA, low (1.26--3.15 ng/mL), medium (≥ 3.15--4.40 ng/mL), and high (≥ 4.40--16.57 ng/mL); for PFOS, low (7.47--18.78 ng/mL), medium (≥ 18.78--24.31 ng/mL), and high (≥ 24.31--54.28 ng/mL). aOne-way ANOVA test of differences across tertiles of maternal PFOA and PFOS exposure. bIncludes cryptorchidism, hypospadias, inguinal hernia, varicocele, testicular hydrocele, incarcerated hernia, phimosis, testicular torsion, chlamydia, gonorrhea, and epididymitis, combined into one variable (yes/no). cChi-square test of differences across tertiles of maternal PFOA and PFOS exposure.                                                                                              

Trend tests on crude sperm concentration and total count did not indicate significant associations with PFOA exposure ([Table 2](#t2){ref-type="table"}). However, estimates from multivariable regression models indicated significant negative trends for sperm concentration and total sperm count associated with *in utero* exposure to PFOA, as well as a 34% reduction (95% CI: --58, 5%) in sperm concentration and a 34% reduction (95% CI: --62, 12%) in total sperm count estimated for the highest exposure group compared with the lowest ([Table 2](#t2){ref-type="table"}). A subanalysis of associations with quintiles of PFOA exposure suggested that the statistically significant negative linear trends for sperm concentration and total sperm count were largely driven by pronounced decreases of sperm concentration and total sperm count among men in the 5th quintiles \[see Supplemental Material, Table S1 (<http://dx.doi.org/10.1289/ehp.1205118>)\]. CASA using CRISMAS Clinical software supported the results from the manual assessment of semen analysis (see Supplemental Material, Table S2). CASA results indicated that men in the high-PFOA tertile had 33% (95% CI: --54, --1%) lower sperm concentrations and 34% (95% CI: --58, 6%) lower total sperm counts compared with men in the low-PFOA group.

###### 

Semen, testicular size, and reproductive hormone characteristics for 169 young Danish men stratified by tertiles of maternal serum PFOA concentrations at pregnancy week 30.

  Parameter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            n     Median (25th--75th percentile)   Spearman's rhoa     ptrenda             Percent difference from low PFOA (95% CI)   Adjusted β (SE)c   Adjusted ptrendc                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- -------------------------------- ------------------- ------------------- ------------------------------------------- ------------------ ------------------ ----------------- --------------- -------
  Sperm concentration (million/mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     168   33 (23--59)                      46 (14--71)         30 (10--66)         --0.11                                      0.15               --7 (--42, 47)     --34 (--58, 5)    --0.11 (0.04)   0.01
  Total sperm count (million)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          123   121 (59--187)                    144 (59--204)       74 (31--223)        --0.15                                      0.10               2 (--42, 81)       --34 (--62, 12)   --0.20 (0.06)   0.001
  Semen volume (mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    123   3 (2-- 4)                        3 (2--4)            3 (2--4)            0.09                                        0.34               14 (--8, 41)       12 (--8, 37)      --0.01 (0.02)   0.54
  Percentage progressive spermatozoa                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   167   67 (60--77)                      60 (51--70)         66 (52--72)         --0.14                                      0.08               --9 (--17, 1)      --8 (--16, 2)     --0.02 (0.01)   0.10
  Percentage morphologically normal spermatozoa                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        152   9 (5--13)                        7 (4--12)           9 (4--13)           --0.05                                      0.54               --24 (--45, 6)     --19 (--42, 13)   --0.05 (0.03)   0.13
  Mean testicular volume (mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          168   15 (12--20)                      15 (11--20)         15 (11--19)         --0.06                                      0.41               1 (--12, 16)       --6 (--18, 8)     --0.01 (0.01)   0.62
  Testosterone (nmol/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                169   22 (18--25)                      21 (17--24)         21 (18--26)         --0.03                                      0.70               --2 (--13, 10)     1 (--10, 12)      0.00 (0.01)     0.70
  Estradiol (nmol/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   169   0.09 (0.08--0.11)                0.09 (0.08--0.12)   0.10 (0.08--0.12)   0.11                                        0.15               1 (--11, 15)       7 (--6, 21)       0.02 (0.01)     0.17
  LH (IU/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            169   4.2 (3.1--5.7)                   4.2 (3.1--5.2)      4.7 (3.8--5.7)      0.12                                        0.11               6 (--11, 27)       24 (4, 48)        0.04 (0.02)     0.03
  FSH (IU/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           169   2.6 (1.8--3.8)                   3.1 (2.4--4.2))     3.3 (2.4--4.8)      0.17                                        0.03               15 (--8, 44)       31 (5, 64)        0.06 (0.02)     0.01
  Inhibin B (pg/mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    169   224 (172--258)                   213 (153--278)      223 (169--262)      --0.02                                      0.82               2 (--14, 21)       0 (--15, 18)      --0.02 (0.02)   0.19
  SHBG (nmol/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        169   26 (22--34)                      26 (20--33)         26 (22--33)         --0.03                                      0.72               --4 (--16, 10)     --3 (--15, 12)    --0.01 (0.01)   0.44
  FAI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  169   78 (67--94)                      82 (66--101)        81 (67--99)         0.02                                        0.85               2 (--11, 17)       3 (--10, 18)      0.01 (0.01)     0.66
  The number of participants in each regression analysis depended on the outcome variable and missing data in the covariates. aSpearman's rho and p-value for PFOA (continuous) and untransformed outcomes. bAll multivariable regression results were adjusted for history of reproductive tract disease, son's body mass index, son's smoking status, maternal smoking during pregnancy, and socioeconomic status. Sperm concentration, total sperm count, progressive spermatozoa, semen volume, and testicular volume were adjusted for abstinence time; sperm concentration was also adjusted for spillage during semen sample collection; progressive spermatozoa was also adjusted for time from ejaculation to semen analysis; reproductive hormones were also adjusted for time of day of blood sampling. cAdjusted β-coefficient for PFOA modeled as a continuous variable in a multivariable linear regression model of ln-transformed outcomes, with adjustment for covariates as indicated above and p-value as a test of linear trend.                                                                                                                                                                                                      

No significant trends of associations between the percentage of progressive spermatozoa and PFOA were indicated in either crude or adjusted results based on the manual assessment ([Table 2](#t2){ref-type="table"}). However, in the comparison between tertiles of exposure, crude results showed that sons in the medium-PFOA group had 10% fewer progressive spermatozoa than those in the low-PFOA group (*p* = 0.02). After adjustment, this association was no longer statistically significant (*p* = 0.06). CASA semen analysis provided somewhat stronger indications of an association between PFOA exposure and the percentage of progressive spermatozoa, with a significant trend in the adjusted analyses and a 13% relative decrease (95% CI: --23, --2%) in the percentage of progressive motile spermatozoa in the high-PFOA group compared with the low-PFOA group \[see Supplemental Material, Table S2 (<http://dx.doi.org/10.1289/ehp.1205118>)\].

For associations of *in utero* exposure to PFOA and sperm morphology, semen volume, or testicular volume, we observed no significant trends or differences between PFOA exposure groups ([Table 2](#t2){ref-type="table"}).

For the reproductive hormones, we observed a trend of higher crude FSH levels with higher PFOA exposure, which remained statistically significant after transformation and adjustment ([Table 2](#t2){ref-type="table"}). Based on the crude analysis of differences between tertiles, sons in the high-PFOA group had 27% higher FSH levels (*p* = 0.03) than sons in the low-PFOA group ([Table 2](#t2){ref-type="table"}). After adjustment, estimated FSH levels were 31% higher (95% CI: 5, 64%) in the high-PFOA group than in the low-PFOA group. LH was not statistically significantly associated with PFOA exposure based on the crude trend test; however, adjusted analyses showed a trend of higher LH with higher *in utero* exposure to PFOA, with a 24% (95% CI: 4, 48%) higher LH level estimated for the high- versus low-PFOA exposure group. We observed no statistically significant associations between *in utero* exposure to PFOA and any of the other reproductive hormones or FAI ([Table 2](#t2){ref-type="table"}).

Analysis of *in utero* exposure to PFOS showed no significant trends or associations for any of the measured semen outcomes or reproductive hormones in either crude or adjusted analyses \[[Table 3](#t3){ref-type="table"}; see also Supplemental Material, Table S3 (<http://dx.doi.org/10.1289/ehp.1205118>)\]. A subanalysis adjusting PFOA trend analyses for PFOS did not alter the observed associations significantly (data not shown).

###### 

Semen, testicular size, and reproductive hormone characteristics for 169 young Danish men stratified by tertiles of maternal serum PFOS concentrations at pregnancy week 30.

  Parameter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                n     Median (25th--75th percentile)   Spearman's rhoa     ptrenda            Percent difference from low PFOS (95% CI)   Adjusted β (SE)c   Adjusted ptrendc                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- -------------------------------- ------------------- ------------------ ------------------------------------------- ------------------ ------------------ ----------------- --------------- ------
  Sperm concentration (million/mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         168   35 (19--58)                      32 (12--62)         37 (17--94)        0.00                                        0.99               --24 (--52, 21)    --1 (--38, 59)    --0.01 (0.01)   0.37
  Total sperm count (million)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              123   103 (55--176)                    77 (42--204)        124 (50--244)      0.01                                        0.87               --36 (--64, 12)    --23 (--56, 38)   --0.02 (0.01)   0.12
  Semen volume (mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        123   3 (2--4)                         3 (2--4)            3 (2--4)           0.05                                        0.56               --8 (--26, 13)     --5 (--24, 18)    0.00 (0.01)     0.58
  Percentage progressive spermatozoa                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       167   66 (57--74)                      67 (54--76)         63 (52--70)        --0.13                                      0.10               0 (--9, 10)        --7 (--16, 2)     0.00 (0.00)     0.17
  Percentage morphologically normal spermatozoa                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            152   9 (4--13)                        8 (4--14)           9 (4--12)          --0.05                                      0.57               --4 (--31, 34)     --14 (--39, 20)   --0.01 (0.01)   0.31
  Mean testicular volume (mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              168   15 (12--20)                      14 (11--20)         15 (12--20)        --0.03                                      0.69               --9 (21, 4)        --4 (--17, 11)    0.00 (0.00)     0.52
  Testosterone (nmol/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    169   22 (19--26)                      20 (16--24)         21 (18--25)        --0.05                                      0.50               --10 (--19, 1)     --5 (--15, 6)     0.00 (0.00)     0.87
  Estradiol (nmol/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       169   0.10 (0.08--0.12)                0.09 (0.08--0.11)   0.1 (0.08--0.12)   0.06                                        0.45               --7 (--19, 5)      1 (--11, 16)      0.00 (0.00)     0.27
  LH (IU/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                169   4 (4--6)                         4 (3--5)            5 (4--6)           0.00                                        0.93               --7 (--22, 12)     --2 (--18, 18)    0.00 (0.00)     0.95
  FSH (IU/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               169   3 (2-- 4)                        3 (2--4)            3 (2--5)           0.12                                        0.13               3 (--18, 29)       20 (--5, 51)      0.01 (0.01)     0.06
  Inhibin B (pg/mL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        169   225 (163--256)                   221 (148--274)      214 (171--266)     --0.01                                      0.91               --6 (--20, 11)     0 (--16, 19)      0.00 (0.00)     0.72
  SHBG (nmol/L)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            169   26 (22--35)                      25 (20--30)         29 (22--36)        0.01                                        0.89               --10 (--22, 2)     5 (--8, 20)       0.00 (0.00)     0.66
  FAI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      169   81 (67--103)                     84 (68--98)         77 (66--94)        --0.03                                      0.68               1 (--12, 16)       --10 (--21, 4)    0.00 (0.00)     0.57
  The number of participants in each regression analysis depended on the outcome variable and missing data in the covariates. aSpearman's rho and p-value for PFOS (continuous) and untransformed outcomes. bAll multivariable regression results were adjusted for history of reproductive tract disease, son's body mass index, son's smoking status, maternal smoking during pregnancy, and socioeconomic status. Sperm concentration, total sperm count, progressive spermatozoa, semen volume, and testicular volume were adjusted for abstinence time; sperm concentration was also adjusted for spillage during semen sample collection; progressive spermatozoa was also adjusted for time from ejaculation to semen analysis; and reproductive hormones were also adjusted for time of day of blood sampling. cAdjusted β-coefficient for PFOS modeled as a continuous variable in a multivariable linear regression model of ln-transformed outcomes, with adjustment for covariates as indicated above and p-value as a test of linear trend.                                                                                                                                                                                                     

Discussion
==========

To the best of our knowledge, this is the first longitudinal study to report associations between *in utero* exposure to PFOA and semen quality and reproductive hormone levels in adult men. We observed trends of lower sperm concentration and total sperm count and higher FSH and LH with higher *in utero* exposure to PFOA. Estimates did not support associations between *in utero* exposure to PFOS and any of the investigated parameters.

For sperm concentration, total sperm count, and LH, there were no statistically significant associations with PFOA in nonparametric models based on the crude, untransformed outcome data; however, we observed significant associations after transforming the outcome data to obtain a normal distribution of residuals and adjusting for potential confounders. Adjustment of the transformed data for potential confounders did not alter the strength of the associations \[see Supplemental Material, Table S4 (<http://dx.doi.org/10.1289/ehp.1205118>)\], indicating that it was the transformation required to perform parametric linear regression analysis rather than adjustment that caused findings to differ between crude and transformed and adjusted data.

A major strength of our study is the longitudinal design, which enabled us to estimate effects of PFOA and PFOS exposure during the crucial prenatal period of male reproductive-organ programming and development on markers of adult reproductive capacity. Because correlations between maternal serum levels of PFOA and PFOS during pregnancy and offspring cord blood levels are generally good (*r* \> 0.82 for PFOA and *r* \> 0.72 for PFOS) ([@r7]; [@r11]) and because PFAA measurements from different trimesters have been shown to be highly correlated (*r* = 0.88 for PFOA and *r* = 0.87 for PFOS) ([@r7]), we believe that the measured exposure in pregnancy week 30 is a good proxy for *in utero* exposure.

Selection bias, which is caused by differences in characteristics between participants and nonparticipants of a study, is a potential concern because of the low participation rate (37.6%) and because former studies have shown that men with fertility problems are more likely to participate in reproduction studies ([@r2]). However, in the present study, participants had no knowledge about their mothers PFAA exposure levels during pregnancy; median (interquartile range) maternal levels of PFOA were almost identical for sons who did not participate in follow-up \[3.7 ng/mL (1.8)\], for those who completed questionnaires \[3.8 ng/mL (2.1)\], and for those who underwent physical examinations \[3.8 ng/mL (1.9)\]. In addition, because of the participants' young age and lack of reproductive experience, it is unlikely that the majority of participants had any knowledge about whether they had fertility problems or not; hence, it is unlikely that participation was related to fecundity.

Two human cross-sectional studies reported that exposure to high PFOA and PFOS combined or PFOS was negatively associated with the percentage of morphologically normal spermatozoa ([@r16]; [@r33]), whereas in our study population, we observed no associations between *in utero* exposure to PFOA or PFOS and the percentage of morphologically normal spermatozoa. One possible explanation of these differences is that relevant time windows of exposure for effects on morphology and sperm production may differ, such that the former is influenced more by current exposures but the latter may be primarily influenced by developmental exposures. This is plausible because the capacity for sperm production later in life is determined during sexual organ development in fetal life, whereas the morphology and motility of spermatozoa are determined during sperm production in adolescence and adulthood. In addition, the association with sperm concentration and total sperm count suggests an effect of PFOA on Sertoli cell development; proliferation of Sertoli cells *in utero* is a determinant for spermatozoa development later in life ([@r29]), but the exact mechanism remains unclear. Furthermore, we observed a positive trend between *in utero* PFOA exposure and LH and FSH levels in adult men ([@r1]; [@r4]; [@r5]; [@r9]; [@r34]); this result supports the general notion that high gonadotrophin concentrations are expected to be associated with low sperm concentration and total sperm count, and corresponds with our finding that men in the high PFOA tertile had a tendency toward lower sperm concentration and total sperm count compared with men in the low tertile.

We observed negative associations between the proportion of motile spermatozoa and PFOA exposure, particularly when the outcome was measured using CASA. Semen concentration and motility results estimated using CASA differed substantially from the results of conventional semen analysis described previously ([@r35]), which may explain the apparent differences in the multivariable regression results between conventional semen analysis and CASA.

Studies on rats exposed *in utero* to ammonium PFOA have not suggested adverse effects on the male reproductive system ([@r3]; [@r39]), and to date, few human studies have investigated possible effects of *in utero* exposure to xenobiotic compounds on male reproduction. In a study investigating early-life exposure to low doses of dioxin, [@r21] reported that associations with reproductive outcomes in adult males appeared to be related to postnatal exposure via breastfeeding rather than exposure *in utero.* Like dioxins, PFAAs are transferred from mother to child by breastfeeding, which would result in postnatal PFAA exposure that would be correlated with prenatal exposure ([@r12]). Therefore, we cannot exclude the possibility that the observed associations may be at least partially explained by effects of postnatal exposure rather than prenatal exposure.

Between 2000 and 2010, background levels of PFOA and PFOS have been declining in the Western world, where the percentage decline in geometric mean concentrations from 2000--2001 to 2010 was reported to be 76% for PFOS and 48% for PFOA ([@r23]). However, the levels measured in 1988--1989 in the mothers of the present study participants (median of 3.8 ng/mL and 21.2 ng/mL for PFOA and PFOS, respectively) were lower than median levels in samples collected during 2003--2004 in Denmark (4.9 ng/mL and 24.5 ng/mL, respectively) ([@r16]) and the United States (9.2 ng/mL and 32.3 ng/mL, respectively) ([@r28]). Hence, *in utero* exposures in our study population were similar to or slightly lower than levels experienced by children born 15 years later.

Our findings suggest that the fetal male reproductive system may be sensitive to background exposure levels of PFOA. Corroboration by other studies would further support the hypothesis that PFOA may be a reproductive toxicant that may be contributing to reduced semen quality in adult men.

Correction
==========

In the manuscript originally published online, some of the p-values in Table 1 were incorrect. They have been corrected here.

Conclusions
===========

Although crude analyses only suggested a trend of higher FSH with increasing PFOA exposure, multivariate analyses suggested a trend of lower sperm concentration and total sperm count and a trend of higher LH and FSH with higher *in utero* exposure to PFOA. Prenatal exposure to PFOS was not related to any of the semen parameters, testicular volume, or reproductive hormones.
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=====================
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Click here for additional data file.
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